SY

Stephen Yoo

Chief Executive Officer at Anjarium Biosciences

Stephen Yoo has a diverse work experience in the field of biosciences and clinical development. Stephen is currently serving as the Chief Executive Officer at Anjarium Biosciences since May 2022. Prior to this, they were the Senior Clinical Advisor at Palvella Therapeutics from December 2016. Stephen also worked as a Senior Clinical Advisor at Vedere Bio II from October 2020 to April 2023.

Stephen held the role of Chief Medical Officer and Head of Research and Development at Third Harmonic Bio from September 2019 to June 2022. Stephen was also an Entrepreneur in Residence at Atlas Venture during the same period. Additionally, they served as a Senior Clinical Advisor at Vedere Bio I from December 2019 to October 2020.

Before these roles, Stephen worked as the Chief Medical Officer at REGENXBIO Inc. from October 2014 to January 2019. Stephen held positions at AstraZeneca, including Medical Science Director from July to October 2014, and Group Director from January to July 2014. Stephen also worked at MedImmune as the Senior Director and Director of Clinical Development from October 2012 to July 2014, and Associate Director of Clinical Development from April 2010 to July 2011.

Stephen commenced their career as an Associate Medical Director at Abbott Laboratories from June 2008 to March 2010.

Stephen Yoo's education history begins in 1993 when they attended the University of California, Berkeley. Stephen pursued a Bachelor of Arts degree in Molecular and Cell Biology, Genetics and completed their studies in 1997.

In 1997, Stephen Yoo enrolled at the David Geffen School of Medicine at UCLA. Stephen studied Medicine and obtained their MD degree in 2003.

Following their medical education, from 2003 to 2004, Stephen Yoo attended the Washington Hospital Center for an Internal Medicine Preliminary Year.

Their education continued from 2004 to 2007 at The University of Texas Southwestern Medical School, where they participated in the Dermatology Residency Program.

Overall, Stephen Yoo's education history showcases their dedication to medical studies and specialization in dermatology.

Links

Previous companies

Vedere Bio logo
Third Harmonic Bio logo
Atlas Venture logo
AstraZeneca logo

Timeline

  • Chief Executive Officer

    May, 2022 - present